Explore the rest of our GHK-Cu peptide range for complementary formulations
Safety, Regulation, and Quality Concerns From a regulatory perspective, AOD 9604 is not approved by the US FDA, and thus it has no approved medical indications
Ready to explore whether AOD-9604 aligns with your metabolic optimization goals
Monitor for red flag symptoms including progressive weakness, bowel or bladder changes, or worsening neurological deficits
Patients with comorbidities need tailored approaches to address their specific needs
Vitamin B12 Fact Sheet for Health Professionals. Office of Dietary Supplements, NIH, 11 March 2021, [Full Article] Mayo Clinic